Southeast Asia Diabetes Devices Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End Use, And Segment Forecasts, 2024

The Southeast Asia diabetes devices market size is anticipated to reach USD 3.58 billion by 2030, registering a CAGR of 9.36% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is growing due to the rising occurrence of diabetes linked to aging, obesity, and poor lifestyle choices. Obesity rates in SEA have surged by 40% from 1990 to 2013. Forecasts indicate that by 2030, over 52.4 million adults and 21 million youth in the region will be obese. As obesity rates continue to increase in the region, the incidence of diabetes is also expected to rise, driving the demand for effective diabetes management devices. The excessive body fat associated with obesity can lead to insulin resistance, a contributor to the onset of diabetes, further exacerbating the already high prevalence of the disease in Southeast Asia.

Diabetes devices play a pivotal role in enhancing the care and management of diabetic patients. The growing demand for these devices is driven by their ability to prevent prolonged hospital stays and reduce mortality rates among individuals with diabetes. The proactive approach enabled by diabetes devices can help prevent serious complications associated with uncontrolled blood sugar levels. By allowing for early detection of hypo- or hyperglycemia, these devices enable prompt action to stabilize glucose levels before they escalate into critical situations. This proactive monitoring can significantly reduce the risk of diabetic emergencies requiring hospitalization, ultimately improving patient outcomes and quality of life.

Increasing awareness about diabetes management through educational campaigns and programs plays a vital role in driving market growth. Educating patients about the importance of regular monitoring and adherence to treatment regimens boosts the demand for related medical devices. For instance, in April 2024, Embecta, a New Jersey company, launched a diabetes education program named emERGE in the Asia-Pacific region. The program is set to commence in 11 countries, including Singapore, Thailand, Vietnam, Australia, South Korea, Japan, Indonesia, Malaysia, the Philippines, and New Zealand. The primary goal of this initiative is to provide educational benefits to around 5,000 healthcare professionals, such as practitioners, diabetes nurse educators, and lead pharmacists, through a series of four interactive webinars.

Southeast Asia Diabetes Devices Market Report Highlights:

In 2023, the insulin delivery devices segment dominated the market with a share of over 50.00% and is expected to grow over the forecast period due to patient preferences, treatment outcomes, and healthcare professional recommendations
Based on distribution channels, the hospital pharmacies segment held the largest share of around 53.00% in 2023. This can be attributed to the accessibility of hospital pharmacies to patients who visit healthcare facilities for various needs, including diabetes management
The retail pharmacies segment is expected to grow at the fastest CAGR during the forecast period due to the expanding network of retail pharmacies in the region
The hospital pharmacy end use segment held a majority share of the market of over 40.00% in 2023. This is attributed to the number of patients with diabetes being hospitalized
The diagnostic centers segment is expected to grow at the fastest CAGR over the forecast period due to their ability to provide quick and accurate results

Product Code: GVR-4-68040-343-9

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Distribution Channel
- 1.2.3. End Use
- 1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Distribution Channel outlook
- 2.2.3. End Use outlook
2.3. Competitive Insights

Chapter 3. Southeast Asia Diabetes Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increase in diabetic prevalence
  - 3.2.1.2. Technological advancements
  - 3.2.1.3. Initiatives by government organizations and NGOs
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Stringent regulations policies and regulations
  - 3.2.2.2. High cost of devices
3.3. Southeast Asia Diabetes Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Southeast Asia Diabetes Devices Market: Type Estimates & Trend Analysis

4.1. Modality Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Southeast Asia Diabetes Devices Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5. BGM Devices
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.2. Self-Monitoring Devices
  - 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.5.2.2. Blood Glucose Monitoring Devices
  - 4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.5.2.3. Testing Strips
  - 4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.5.2.4. Lancets
  - 4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5.3. Continuous Glucose Monitoring Devices
  - 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.5.3.2. Sensors
  - 4.5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.5.3.3. Transmitter
  - 4.5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.5.3.4. Receiver
  - 4.5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Insulin Delivery Devices
- 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.2. Pumps
  - 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.3. Pens
  - 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.4. Syringes
  - 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.5. Jet Injector
  - 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Southeast Asia Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis

5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Southeast Asia Diabetes Devices Market by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 5.4.1. Hospital Pharmacies
  - 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Retail Pharmacies
  - 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 5.4.2.2. Diabetes Clinics/Centers
  - 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 5.4.2.3. Online Pharmacies
  - 5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  - 5.4.2.4. Others
  - 5.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Southeast Asia Diabetes Devices Market: End Use Estimates & Trend Analysis

6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Southeast Asia Diabetes Devices Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 6.4.1. Hospitals
  - 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 6.4.2. Diagnostic Centers
  - 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Homecare
  - 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
- 7.4.1. Medtronic plc.
  - 7.4.1.1. Company overview
  - 7.4.1.2. Financial performance
  - 7.4.1.3. Product benchmarking
  - 7.4.1.4. Strategic initiatives
- 7.4.2. Abbott Laboratories
  - 7.4.2.1. Company overview
  - 7.4.2.2. Financial performance
  - 7.4.2.3. Product benchmarking
  - 7.4.2.4. Strategic initiatives
- 7.4.3. F.Hoffmann-La-Ltd.
  - 7.4.3.1. Company overview
  - 7.4.3.2. Financial performance
  - 7.4.3.3. Product benchmarking
  - 7.4.3.4. Strategic initiatives
- 7.4.4. Bayer AG
  - 7.4.4.1. Company overview
  - 7.4.4.2. Financial performance
  - 7.4.4.3. Product benchmarking
  - 7.4.4.4. Strategic initiatives
- 7.4.5. Lifescan, Inc.
  - 7.4.5.1. Company overview
  - 7.4.5.2. Financial performance
  - 7.4.5.3. Product benchmarking
  - 7.4.5.4. Strategic initiatives
- 7.4.6. B Braun Melsungen AG
  - 7.4.6.1. Company overview
  - 7.4.6.2. Financial performance
  - 7.4.6.3. Product benchmarking
  - 7.4.6.4. Strategic initiatives
- 7.4.7. Dexcom Inc.
  - 7.4.7.1. Company overview
  - 7.4.7.2. Financial performance
  - 7.4.7.3. Product benchmarking
  - 7.4.7.4. Strategic initiatives
- 7.4.8. Insulet Corporation
  - 7.4.8.1. Company overview
  - 7.4.8.2. Financial performance
  - 7.4.8.3. Product benchmarking
  - 7.4.8.4. Strategic initiatives
- 7.4.9. Ypsomed Holdings
  - 7.4.9.1. Company overview
  - 7.4.9.2. Financial performance
  - 7.4.9.3. Product benchmarking
  - 7.4.9.4. Strategic initiatives
- 7.4.10. Companion Medical
  - 7.4.10.1. Company overview
  - 7.4.10.2. Financial performance
  - 7.4.10.3. Product benchmarking
  - 7.4.10.4. Strategic initiatives
- 7.4.11. Sanofi
  - 7.4.11.1. Company overview
  - 7.4.11.2. Financial performance
  - 7.4.11.3. Product benchmarking
  - 7.4.11.4. Strategic initiatives
- 7.4.12. Valeritas Holding Inc.
  - 7.4.12.1. Company overview
  - 7.4.12.2. Financial performance
  - 7.4.12.3. Product benchmarking
  - 7.4.12.4. Strategic initiatives
- 7.4.13. Novo Nordisk
  - 7.4.13.1. Company overview
  - 7.4.13.2. Financial performance
  - 7.4.13.3. Product benchmarking
  - 7.4.13.4. Strategic initiatives
- 7.4.14. Arkay, Inc.
  - 7.4.14.1. Company overview
  - 7.4.14.2. Financial performance
  - 7.4.14.3. Product benchmarking
  - 7.4.14.4. Strategic initiatives

Product Code: GVR-4-68040-343-9

List of Tables

Table 1 List of abbreviations
Table 2 Southeast Asia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 3 Southeast Asia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 4 Southeast Asia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 5 Indonesia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 6 Indonesia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Indonesia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 8 Thailand Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 9 Thailand Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 10 Thailand Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 11 Philippines Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 12 Philippines Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 Philippines Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 14 Malaysia Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 15 Malaysia Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Malaysia Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 17 Vietnam Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 18 Vietnam Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Vietnam Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 20 Myanmar Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 21 Myanmar Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 Myanmar Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)
Table 23 Singapore Diabetes Devices Market, by type, 2018 - 2030 (USD Million)
Table 24 Singapore Diabetes Devices Market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Singapore Diabetes Devices Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Southeast Asia Diabetes Devices Market: market outlook
Fig. 9 Southeast Asia Diabetes Devices competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Southeast Asia Diabetes Devices Market: Driver impact
Fig. 14 Southeast Asia Diabetes Devices Market: Restraint impact
Fig. 15 Southeast Asia Diabetes Devices Market: Type movement analysis
Fig. 16 Southeast Asia Diabetes Devices Market: Type outlook and key takeaways
Fig. 17 Self Monitoring Devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Blood Glucose Meter market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Testing Strips market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Lancets market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Continuous Glucose Monitoring Devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Sensors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Transmitter market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Receiver market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Insulin Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Pens market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Pumps market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Syringes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Jet Injector market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Southeast Asia Diabetes Devices Market: Distribution channel movement Analysis
Fig. 31 Southeast Asia Diabetes Devices Market: Distribution channel outlook and key takeaways
Fig. 32 Hospital Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Retail Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Diabetes Clinics/Centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Online Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Southeast Asia Diabetes Devices Market: End-use movement analysis
Fig. 38 Southeast Asia Diabetes Devices Market: End-use outlook and key takeaways
Fig. 39 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Diagnostic Centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Homecare market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Southeast Asia Diabetes Devices Market Revenue, By country, 2023 & 2030 (USD Million)
Fig. 43 Southeast Asia Diabetes Devices Market: End-use movement analysis
Fig. 44 Indonesia Diabetes Devices Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Thailand Diabetes Devices Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Philippines Diabetes Devices Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Malaysia Diabetes Devices Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Fig. 48 Vietnam Diabetes Devices Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Fig. 49 Myanmar Diabetes Devices Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Fig. 50 Singapore Diabetes Devices Market Estimates & Forecasts, 2018 - 2030 (USD Million)

Southeast Asia Diabetes Devices Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End Use, And Segment Forecasts, 2024 - 2030

Description

Table of Contents

List of Tables

Southeast Asia Diabetes Devices Market Growth & Trends:

Southeast Asia Diabetes Devices Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Southeast Asia Diabetes Devices Market Variables, Trends & Scope

Chapter 4. Southeast Asia Diabetes Devices Market: Type Estimates & Trend Analysis

Chapter 5. Southeast Asia Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis

Chapter 6. Southeast Asia Diabetes Devices Market: End Use Estimates & Trend Analysis

Chapter 7. Competitive Landscape

List of Tables

List of Figures